Free Trial

Leigh Baldwin & CO. LLC Purchases New Stake in Exelon Co. (NASDAQ:EXC)

Exelon logo with Utilities background

Leigh Baldwin & CO. LLC bought a new stake in Exelon Co. (NASDAQ:EXC - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 247,500 shares of the company's stock, valued at approximately $932,000.

Other hedge funds also recently made changes to their positions in the company. Vanguard Group Inc. boosted its holdings in shares of Exelon by 2.5% in the fourth quarter. Vanguard Group Inc. now owns 127,335,351 shares of the company's stock valued at $4,792,903,000 after acquiring an additional 3,064,673 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its position in shares of Exelon by 37.2% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 27,618,055 shares of the company's stock worth $1,039,545,000 after buying an additional 7,483,873 shares in the last quarter. Geode Capital Management LLC grew its position in shares of Exelon by 1.4% in the fourth quarter. Geode Capital Management LLC now owns 26,314,296 shares of the company's stock valued at $988,080,000 after purchasing an additional 368,505 shares during the last quarter. FMR LLC grew its holdings in Exelon by 46.9% during the 4th quarter. FMR LLC now owns 17,306,652 shares of the company's stock valued at $651,422,000 after buying an additional 5,524,103 shares during the last quarter. Finally, Deutsche Bank AG lifted its position in shares of Exelon by 11.1% in the fourth quarter. Deutsche Bank AG now owns 17,089,308 shares of the company's stock valued at $643,242,000 after acquiring an additional 1,706,184 shares in the last quarter. Hedge funds and other institutional investors own 80.92% of the company's stock.

Exelon Price Performance

NASDAQ:EXC traded up $1.18 during midday trading on Thursday, hitting $43.43. 8,463,150 shares of the stock were exchanged, compared to its average volume of 7,272,550. The business has a 50-day moving average price of $45.22 and a two-hundred day moving average price of $41.49. The company has a current ratio of 0.87, a quick ratio of 0.78 and a debt-to-equity ratio of 1.61. The company has a market capitalization of $43.84 billion, a price-to-earnings ratio of 17.73, a P/E/G ratio of 2.86 and a beta of 0.43. Exelon Co. has a one year low of $34.01 and a one year high of $48.11.

Exelon (NASDAQ:EXC - Get Free Report) last released its earnings results on Thursday, May 1st. The company reported $0.92 EPS for the quarter, beating the consensus estimate of $0.86 by $0.06. The business had revenue of $6.71 billion during the quarter, compared to analyst estimates of $6.30 billion. Exelon had a net margin of 10.68% and a return on equity of 9.52%. The business's quarterly revenue was up 11.1% on a year-over-year basis. During the same period in the prior year, the business earned $0.68 earnings per share. Sell-side analysts predict that Exelon Co. will post 2.64 EPS for the current year.

Exelon Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, June 13th. Investors of record on Monday, May 12th will be paid a $0.40 dividend. The ex-dividend date of this dividend is Monday, May 12th. This represents a $1.60 dividend on an annualized basis and a yield of 3.68%. Exelon's dividend payout ratio is currently 59.48%.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on EXC. BMO Capital Markets raised their price objective on Exelon from $46.00 to $50.00 and gave the stock an "outperform" rating in a report on Monday, April 28th. Morgan Stanley lifted their target price on shares of Exelon from $46.00 to $48.00 and gave the company an "equal weight" rating in a report on Thursday, March 20th. Evercore ISI increased their price objective on shares of Exelon from $48.00 to $51.00 and gave the company an "in-line" rating in a research report on Friday, May 2nd. Wells Fargo & Company upped their target price on Exelon from $46.00 to $50.00 and gave the company an "equal weight" rating in a research report on Friday, May 2nd. Finally, UBS Group upped their price objective on Exelon from $45.00 to $47.00 and gave the company a "neutral" rating in a research note on Friday, March 21st. One research analyst has rated the stock with a sell rating, five have given a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, Exelon presently has a consensus rating of "Hold" and a consensus target price of $47.30.

Get Our Latest Stock Analysis on EXC

Exelon Company Profile

(Free Report)

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.

See Also

Institutional Ownership by Quarter for Exelon (NASDAQ:EXC)

Should You Invest $1,000 in Exelon Right Now?

Before you consider Exelon, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exelon wasn't on the list.

While Exelon currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

7 Nuclear Stocks One Announcement Away from Exploding
3 AI ETFs for Steady Gains in 2025 (Without the Wild Volatility)
Goldman Sachs Warns of 20% Market Drop—Are They Right?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines